Mo-99/Tc-99m Generators: Transient Equilibrium

The Mo-99/Tc-99m generator supplies most of nuclear medicine's daily workload, and everything about how it is operated follows from one piece of physics: the transient equilibrium between a 66-hour parent and a 6-hour daughter. That relationship sets when to elute, how much Tc-99m to expect, why the real yield falls short of the textbook maximum, and why a molybdenum breakthrough test must precede patient use.

Introduction

Technetium-99m is the most widely used diagnostic radionuclide because it has nearly ideal properties: a 140 keV gamma photon well matched to gamma cameras, a six-hour half-life long enough to image and short enough to limit dose, and a chemistry that labels a wide range of radiopharmaceuticals. None of that would be practical without a convenient, on-site supply, and that supply is the molybdenum-99/technetium-99m generator — a shielded alumina column that holds the parent Mo-99 and releases its daughter Tc-99m on demand. ^{1, 2}

This article explains the decay physics of the generator, derives the optimal elution time, quantifies why real yields fall short of theory, and connects the regrowth curve to the regulatory and quality-control requirements that govern generator use. DRPS supports nuclear medicine programs with this analysis through its PET/CT and nuclear medicine physics and radioactive material license support services across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

Topic Explanation

Parent, daughter, and the column

Mo-99 is produced primarily by fission of uranium-235 targets and is loaded onto an alumina (Al₂O₃) column as molybdate. Mo-99 decays with a half-life of about 66 hours, and the great majority of those decays populate the metastable state Tc-99m. Technetium and molybdenum have different chemistry: pertechnetate (TcO₄⁻) is weakly bound to the column and washes off readily in saline, while molybdate stays bound. Drawing sterile saline through the column — elution, or "milking" — therefore carries off the accumulated Tc-99m and leaves the Mo-99 behind to keep producing more. ^{1, 2}

The behavior of this system is entirely a question of two decay rates. For any radionuclide the decay constant is

λ = \frac{ln 2}{T _{1/2}},

giving $λ_{Mo} = ln 2/65.94 h \approx 0.0105 h^{- 1}$ and $λ_{Tc} = ln 2/6.01 h \approx 0.115 h^{- 1}$ . The daughter decays roughly eleven times faster than the parent, and that ratio is what makes the system a transient equilibrium rather than a secular one. ^{2, 3}

What "transient equilibrium" means

After an elution strips the column of Tc-99m, the daughter begins to regrow. Its activity rises, reaches a maximum, and then begins to fall — but once equilibrium is established it falls only as fast as the parent supply dwindles, decaying with Mo-99's apparent 66-hour half-life rather than its own 6-hour half-life. This is transient equilibrium: it occurs when the parent half-life exceeds the daughter half-life by a moderate factor (here about eleven). When the parent half-life is vastly longer, the equilibrium is "secular" and the daughter activity equals the parent activity; the Mo-99/Tc-99m case is intermediate, and the branching ratio pushes the daughter slightly below the parent. For context on the emission characteristics that make Tc-99m and its PET cousins useful, see common PET and RPT isotopes.

Key Technical Principles

The regrowth equation

Starting from a fully eluted column (no Tc-99m at time zero), the daughter activity grows according to the Bateman relationship for a parent-daughter chain:

A_{Tc} (t) = \frac{f λ _{Tc}}{λ _{Tc} - λ _{Mo}} A_{Mo} (0) (e^{- λ_{Mo} t} - e^{- λ_{Tc} t})

where $A_{Mo} (0)$ is the Mo-99 activity at the moment of elution and $f$ is the branching fraction — the probability that a Mo-99 decay produces Tc-99m, about 0.875. The term in parentheses is zero at $t = 0$ (the column is empty), rises as the fast $e^{- λ_{Tc} t}$ term dies away, and then declines with the slow $e^{- λ_{Mo} t}$ term. ^{2, 3}

When to elute

The maximum Tc-99m activity occurs where the derivative of the regrowth curve is zero, which gives a closed-form optimal interval:

t_{m a x} = \frac{ln ( λ _{Tc} / λ _{Mo} )}{λ _{Tc} - λ _{Mo}} = \frac{ln ( 0.115/0.0105 )}{0.115 - 0.0105} \approx \frac{2.40}{0.105} \approx 22.9 h .

Tc-99m regrows to its maximum roughly 23 hours after the previous elution. This is the physical basis for the standard clinical rhythm of one elution each morning: by the next day the column has recovered essentially all the activity it can hold. The table below shows how completely Tc-99m has regrown as a function of the time since the last elution, expressed as a fraction of the maximum available activity. ^{2, 4}

Time since last elution	Approx. % of maximum available Tc-99m	Practical note
3 hours	~37%	Too soon; little regrowth
6 hours	~61%	A partial second elution is possible but small
12 hours	~88%	Most activity already recovered
23 hours	~100%	Theoretical maximum
24 hours	~100%	Standard once-daily schedule

Eluting again shortly after a previous elution yields little, because the parent has not had time to feed the daughter back up. Crucially, elution frequency does not change how much Mo-99 decays — the parent sets the total daily output — so frequent elutions simply split the same activity into smaller vials. ⁴

The equilibrium ratio and why the daughter sits below the parent

Long after $t_{m a x}$ , the fast exponential has vanished and the activity ratio approaches a constant:

\frac{A _{Tc}}{A _{Mo}}_{eq} = \frac{f λ _{Tc}}{λ _{Tc} - λ _{Mo}} = 0.875 \times \frac{0.115}{0.105} \approx 0.96.

If every Mo-99 decay produced Tc-99m ( $f = 1$ ), this ratio would be about 1.10, and the daughter activity on the column would briefly exceed the parent's — the hallmark of transient equilibrium. But because only about 87.5% of Mo-99 decays route through Tc-99m (the rest go directly toward ground-state Tc-99), the real on-column daughter activity settles a few percent below the parent activity. This branching correction is a common source of confusion and is exactly why measured yields never reach the naive "daughter equals parent" expectation. ^{2, 3}

Why real yield falls short of theory

Three effects stack up to make the vial you draw smaller than the Bateman ideal:

Branching. Only ~87.5% of parent decays feed the daughter, capping the equilibrium ratio near 0.96 rather than at or above 1.0.
Elution efficiency. No elution strips the column perfectly; a fraction of the Tc-99m remains behind, so the recovered activity is a large but incomplete share of what was present.
Parent decay since calibration. The generator's Mo-99 has been decaying since the manufacturer's calibration time, so a generator late in its one-to-two-week useful life delivers far less than it did when new.

Together these explain why the dose-calibrator reading on an elution is routinely well below a back-of-envelope estimate that assumes perfect branching, perfect elution, and no parent decay. For how the eluate is then assayed and controlled, see dose calibrator quality control and radiochemical purity and TLC quality control.

A worked activity estimate

Consider a generator calibrated at $A_{Mo} (0) = 1.85$ GBq (50 mCi) of Mo-99 at the manufacturer's reference time. Suppose the first morning elution occurs at that reference time, after the column has fully regrown. At equilibrium the on-column Tc-99m activity is about

A_{Tc} \approx 0.96 \times A_{Mo} = 0.96 \times 1.85 GBq \approx 1.78 GBq .

A realistic elution efficiency of around 90% recovers roughly 1.6 GBq (about 43 mCi) in the vial — already noticeably less than the 1.85 GBq of parent present. Now move three days downstream. The Mo-99 has decayed by

e^{- λ_{Mo} t} = e^{- 0.0105 \times 72} = e^{- 0.756} \approx 0.47,

so only about 0.87 GBq of parent remains, and the same morning elution now delivers on the order of 0.75 GBq (about 20 mCi). In under half a week the usable daily output has fallen by more than half — which is exactly why generator ordering is scheduled around the calibration date and expected weekly decline rather than treated as a constant supply. ²

Clinical Impact

Scheduling and supply

The regrowth physics directly shapes the clinical day. A department that elutes each morning gets near-maximal activity for the day's first studies; a request for a late-afternoon high-activity study may require a second, smaller elution or careful planning around the morning vial's decay. Because Tc-99m decays with a six-hour half-life after elution, an afternoon dose drawn from a morning elution has already lost roughly a quarter to a half of its activity, which must be accounted for in dose preparation. Understanding the curve is what lets a technologist and physicist plan volumes and timing so that each patient receives the prescribed activity without waste. ^{2, 4}

Breakthrough and patient dose

The same long parent half-life that makes the generator convenient also makes Mo-99 a dangerous contaminant if it escapes into the eluate. Mo-99 emits high-energy betas and gammas and persists far longer than Tc-99m, so any molybdenum "breakthrough" into an injected dose delivers unnecessary radiation to the patient with no diagnostic benefit. Alumina breakthrough from the column is a separate concern that can interfere with radiopharmaceutical labeling. Both are the reason eluate quality control is mandatory rather than optional. The NRC has documented cases of generators failing the breakthrough test in routine use, underscoring that the test catches real, not hypothetical, events. ^{1, 5, 8}

Practical Optimization Tips

A sound generator program operationalizes the physics into a short, disciplined routine.

1. Elute on a schedule matched to demand

Elute once each morning for routine workloads; the ~23-hour interval recovers essentially all available activity. Plan second elutions only when a specific clinical need justifies the small yield they provide.

2. Measure and record every eluate

Assay each elution in a quality-controlled dose calibrator and record the Tc-99m activity, volume, and concentration. Track the trend over the generator's life so a sudden drop — a sign of a problem — is obvious.

3. Perform the molybdenum breakthrough test on each eluate

Before patient use, measure the Mo-99 concentration in the eluate, typically by assaying the vial inside a lead "moly shield" that absorbs the 140 keV Tc-99m photons while passing the higher-energy Mo-99 photons, then comparing to the unshielded Tc-99m reading. Confirm the result is within the regulatory limit.

4. Check for alumina breakthrough

Use a colorimetric spot test on the eluate to confirm aluminum ion concentration is within specification, because excess alumina can compromise labeling of Tc-99m radiopharmaceuticals.

5. Shield the generator and eluate appropriately

Store and elute the generator behind adequate shielding, and handle the eluate with syringe and vial shields. Coordinate shielding and storage with the facility's radiation safety officer program.

Common pitfalls to avoid

Expecting daughter activity to equal parent activity. The branching ratio caps the equilibrium ratio near 0.96, not 1.0.
Eluting too frequently to "get more." Total output is fixed by Mo-99 decay; frequent elutions only fractionate the same activity.
Forgetting parent decay over the generator's life. A week-old generator delivers a small fraction of its day-one activity.
Skipping or deferring the breakthrough test. The test is required on each eluate before patient use, not weekly or on suspicion.
Ignoring alumina breakthrough. Excess aluminum can quietly degrade labeling yield and image quality.

Regulatory Considerations

Generator operations are governed by federal and Agreement State rules on the medical use of byproduct material, and the molybdenum breakthrough limit is a hard, codified requirement tied directly to patient dose. The U.S. Nuclear Regulatory Commission (NRC), under 10 CFR 35.204, prohibits administering a Tc-99m radiopharmaceutical containing more than 0.15 kilobecquerel of Mo-99 per megabecquerel of Tc-99m (equivalently, 0.15 microcurie of Mo-99 per millicurie of Tc-99m), and requires a licensee that elutes Mo-99/Tc-99m generators to measure the Mo-99 concentration in each eluate to demonstrate compliance. ⁵

Records of these measurements must be retained under 10 CFR 35.2204. The handling, calibration, and preparation of the eluate also fall under 10 CFR Part 20 for radiation protection and, for compounding and dispensing practice, under USP General Chapter <825> on radiopharmaceutical preparation, compounding, dispensing, and repackaging. ^{5, 6, 7}

Agreement States administer equivalent programs. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that license medical use under their own radiation-control rules, while Washington, DC and Delaware are regulated directly by the NRC for byproduct material. A facility must confirm which authority issues its license and which breakthrough-testing, recordkeeping, and reporting requirements apply. The NRC's program-specific licensing guidance for medical use, NUREG-1556 Volume 9, describes the expectations a medical-use licensee must meet for radiation safety procedures, including generator handling. Program setup is best coordinated with radioactive material license support and medical physics consulting. ^{5, 9}

Frequently Asked Questions (FAQs)

What is transient equilibrium in a Mo-99/Tc-99m generator?

Transient equilibrium is the state reached when the parent half-life (Mo-99, about 66 hours) is longer than the daughter half-life (Tc-99m, about 6 hours) by a moderate factor. After several daughter half-lives, Tc-99m activity grows until it tracks the slow decay of Mo-99, decaying with the parent's apparent half-life. Because not every Mo-99 decay produces Tc-99m, the daughter activity settles slightly below the parent activity rather than above it.

When should a Mo-99/Tc-99m generator be eluted for maximum yield?

Tc-99m regrows to its maximum roughly 23 hours after the previous elution. In practice most departments elute once each morning, which is close enough to the theoretical optimum to recover nearly all the available activity while fitting the clinical schedule.

Why is the eluted Tc-99m activity always less than the theoretical maximum?

Several factors reduce real yield below the Bateman-equation ideal: only about 87.5% of Mo-99 decays feed the Tc-99m state, elution efficiency is less than 100%, and the generator has been losing Mo-99 continuously since calibration. The combination means typical elutions recover a large but incomplete fraction of the theoretical activity.

What is molybdenum breakthrough and why is it tested?

Breakthrough is Mo-99 (or alumina from the column) that escapes into the Tc-99m eluate. Mo-99 is a long-lived, high-energy contaminant that would deliver unnecessary dose to the patient, so NRC regulations cap it at 0.15 kilobecquerel of Mo-99 per megabecquerel of Tc-99m and require the concentration to be measured on each eluate before patient use.

Does eluting more often give more total Tc-99m?

No. Eluting again soon after a previous elution yields little, because Tc-99m has not had time to regrow. The parent decays at the same rate regardless of elution frequency, so frequent elution produces several small vials rather than more total activity.

Why does Tc-99m decay with a 66-hour half-life after equilibrium instead of 6 hours?

Once equilibrium is established on the column, the daughter is continuously replenished by the parent, so its activity is governed by the parent's supply. The daughter therefore appears to decay with the parent's 66-hour half-life until it is separated by elution, after which the freshly eluted Tc-99m decays with its own 6-hour half-life.

When should a facility involve a medical physicist in generator operations?

A qualified medical physicist should help establish elution and breakthrough testing procedures, dose-calibrator quality control, shielding and storage for the generator and eluate, and the records required by NRC or Agreement State rules, especially when a nuclear medicine program is new, expanding, or adding therapy radionuclides.

Key Takeaways

The generator runs on transient equilibrium. A 66-hour parent and a 6-hour daughter produce a regrowth curve that governs every operational decision.
Elute at about 23 hours. $t_{m a x} = ln (λ_{Tc} / λ_{Mo}) / (λ_{Tc} - λ_{Mo}) \approx 23$ h, which is why once-daily morning elution is standard.
The daughter sits below the parent. Branching (~87.5%) caps the equilibrium activity ratio near 0.96, not at or above 1.0.
Real yield is less than theory. Branching, imperfect elution efficiency, and parent decay since calibration all reduce the recovered activity.
Elution frequency does not increase total output. Mo-99 decay fixes the daily total; frequent elutions only fractionate it.
Breakthrough testing is mandatory. NRC caps Mo-99 at 0.15 kBq/MBq Tc-99m and requires each eluate to be measured before patient use.

Conclusion

Everything that looks like operational lore about the Tc-99m generator — milk it in the morning, don't bother milking it twice, expect less from an old generator, always run the moly test — is a direct consequence of one parent-daughter decay relationship. The transient equilibrium between Mo-99 and Tc-99m sets the regrowth curve, the ~23-hour optimum, the sub-unity equilibrium ratio, and the shortfall between theoretical and real yield. Reading the generator through that physics turns a set of memorized rules into a predictable system, and it anchors the quality-control and regulatory steps — breakthrough testing above all — that keep each Tc-99m dose both effective and safe.

How DRPS Can Help

Diagnostic Radiation Physics Services helps nuclear medicine programs operate generators safely and in compliance. This includes establishing elution and molybdenum breakthrough testing procedures, dose-calibrator quality control, generator and eluate shielding and storage reviews, recordkeeping aligned with NRC and Agreement State rules, and staff training, delivered through our PET/CT and nuclear medicine physics, radioactive material license support, and radiation safety officer services.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A generator is a small reactor of convenience sitting in the hot lab. Respecting its physics is what makes it both productive and safe.

Related Resources

References

International Atomic Energy Agency. Technetium-99m Radiopharmaceuticals: Status and Trends. IAEA Radioisotopes and Radiopharmaceuticals Series No. 1. Vienna: IAEA; 2009. iaea.org
Cherry SR, Sorenson JA, Phelps ME. Physics in Nuclear Medicine. 4th ed. Philadelphia: Elsevier Saunders; 2012. elsevier.com
International Commission on Radiological Protection. ICRP Publication 107: Nuclear Decay Data for Dosimetric Calculations. Ann ICRP. 2008;38(3). icrp.org
National Nuclear Data Center, Brookhaven National Laboratory. NuDat: nuclear decay data for Mo-99 and Tc-99m. nndc.bnl.gov
U.S. Nuclear Regulatory Commission. 10 CFR 35.204: Permissible molybdenum-99, strontium-82, and strontium-85 concentrations. ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR 35.2204: Records of molybdenum-99, strontium-82, and strontium-85 concentrations. ecfr.gov
United States Pharmacopeia. General Chapter <825>: Radiopharmaceuticals — Preparation, Compounding, Dispensing, and Repackaging. usp.org
U.S. Nuclear Regulatory Commission. Information Notice 2008-22: Molybdenum-99/Technetium-99m Generator Eluate Breakthrough. 2008. nrc.gov
U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 9, Revision 3: Consolidated Guidance About Materials Licenses — Program-Specific Guidance About Medical Use Licenses. nrc.gov